Ketotifen Fumarate Patent Expiration

Ketotifen Fumarate was first introduced by Alcon Research Ltd in its drug Zaditor on Oct 19, 2006. Other drugs containing Ketotifen Fumarate are Children'S Alaway, Acuvue Theravision With Ketotifen, Alaway. 8 different companies have introduced drugs containing Ketotifen Fumarate.


Ketotifen Fumarate Patents

Given below is the list of patents protecting Ketotifen Fumarate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Acuvue Theravision With Ketotifen US9962376 Methods and ophthalmic devices used in the treatment of ocular allergies Jun 27, 2030 Johnson Johnson Visn
Acuvue Theravision With Ketotifen US9474746 Methods for stabilizing oxidatively unstable compositions Mar 27, 2028 Johnson Johnson Visn



Ketotifen Fumarate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ketotifen Fumarate Generic API Manufacturers

Several generic applications have been filed for Ketotifen Fumarate. The first generic version for Ketotifen Fumarate was by Apotex Inc and was approved on May 9, 2006. And the latest generic version is by Bausch And Lomb Inc and was approved on Sep 24, 2020.

Given below is the list of companies who have filed for Ketotifen Fumarate generic, along with the locations of their manufacturing plants worldwide.